| Literature DB >> 31189570 |
Yujun Lin1,2, Cheng Cui1, Min Su1, Xiaohong Tian1, Yuanmao Huang1, Jin Zhao1, Laijun Lai3,4.
Abstract
Immune responses are tightly controlled by T cell costimulatory and coinhibitory molecules. In this study, we identify Skint8 as a new member of the T cell coinhibitory group, whose extracellular domains share significant homology with existing B7 family members. Skint8 mRNA is expressed in resting and activated B cells, monocytes, and CD4 T cells. The Skint8 putative receptor is expressed on activated CD4 and CD8 T cells, B cells, monocytes and dendritic cells. Recombinant Skint8-IgG Fc fusion protein inhibits T cell proliferation, activation, and cytokine production in vitro. In vivo administration of Skint8-IgG Fc reduces T cell activation and alleviates experimental autoimmune encephalomyelitis in mice. The findings broaden our understanding of the regulation of immune responses and may have implications for treating immune-related diseases.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31189570 PMCID: PMC6615975 DOI: 10.4049/jimmunol.1800639
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422